0001437749-19-000343.txt : 20190104
0001437749-19-000343.hdr.sgml : 20190104
20190104160131
ACCESSION NUMBER: 0001437749-19-000343
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190102
FILED AS OF DATE: 20190104
DATE AS OF CHANGE: 20190104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hornung William Karl
CENTRAL INDEX KEY: 0001612066
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37942
FILM NUMBER: 19509931
MAIL ADDRESS:
STREET 1: C/O CONTRAVIR PHARMACEUTICALS, INC.
STREET 2: 420 LEXINGTON AVE., SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001053691
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300645032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: (434) 220-0718
MAIL ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER COMPANY:
FORMER CONFORMED NAME: RestorGenex Corp
DATE OF NAME CHANGE: 20140307
FORMER COMPANY:
FORMER CONFORMED NAME: Stratus Media Group, Inc
DATE OF NAME CHANGE: 20080722
FORMER COMPANY:
FORMER CONFORMED NAME: FERIS INTERNATIONAL, INC.
DATE OF NAME CHANGE: 20080228
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-01-02
0001053691
Diffusion Pharmaceuticals Inc.
DFFN
0001612066
Hornung William Karl
1317 CARLTON AVENUE, SUITE 200
CHARLOTTESVILLE
VA
22902
1
Chief Financial Officer
Stock Option (Right to Buy)
2.10
2019-01-02
4
A
0
16334
0
A
2029-01-02
Common Stock
16334
16334
D
The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2019.
/s/ William Hornung
2019-01-04